Limaca's Precision-GI Endoscopic Biopsy Device Designated a Breakthrough Device

Limaca Medical’s Precision-GI endoscopic ultrasound biopsy device has been designated a Breakthrough Device by the FDA.

The device, which is deployed through an instrument channel in an endoscope, features a motorized, rotational cutting needle for taking biopsies of tumors.

The device yields a greater quantity of diagnostically relevant biopsy tissue for diagnosis of pancreatic cancer and other life-threatening GI cancers more quickly and less traumatically than existing devices, the Israel-based company said.